Buy SANTRA (ANASTROZOLE) 1mg Film Tablet Online

Description

SANTRA 1mg Film Tablet, manufactured by Sandoz, is a highly effective medication used in the treatment of hormone receptor-positive breast cancer. Each box contains 28 film-coated tablets, with each tablet containing 1 mg of Anastrozole, the active substance.

Key Features:

1. Effective Aromatase Inhibitor: SANTRA 1mg contains Anastrozole, a potent aromatase inhibitor. Anastrozole works by reducing the amount of estrogen in the body, which is crucial in slowing down or stopping the growth of estrogen receptor-positive breast cancer cells.
2. Breast Cancer Treatment: SANTRA 1mg is primarily indicated for the treatment of postmenopausal women with hormone receptor-positive early breast cancer. It is also used in the treatment of advanced or metastatic breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.
3. Hormone Therapy: By lowering estrogen levels, SANTRA 1mg helps in reducing the risk of breast cancer recurrence after surgery and other treatments. It is often prescribed as part of adjuvant therapy to prevent the cancer from coming back.
4. Once-Daily Dosing: SANTRA 1mg is designed for convenient once-daily oral administration. This simple dosing regimen helps ensure patient compliance and consistent therapeutic effects.
5. Well-Tolerated: SANTRA 1mg is generally well-tolerated, with a favorable side effect profile compared to other hormone therapies. Common side effects may include hot flashes, joint pain, and nausea. However, these side effects are typically mild and manageable.

Usage Guidelines:

• Administration: SANTRA 1mg tablets should be taken orally, once daily, preferably at the same time each day. The tablet can be taken with or without food.
• Dosage: The recommended dosage of SANTRA 1mg for adults is one 1 mg tablet per day. The treatment duration and specific dosing regimen should be determined by the treating physician based on individual patient needs and response to therapy.
• Monitoring: Regular monitoring of the patient’s condition and response to treatment is essential. Periodic bone density assessments may be recommended, as long-term use of aromatase inhibitors can lead to decreased bone mineral density.

SANTRA 1mg Film Tablet by Sandoz provides an effective solution for managing hormone receptor-positive breast cancer in postmenopausal women. With its proven efficacy, convenient once-daily dosing, and well-tolerated profile, SANTRA 1mg is a trusted option for patients and healthcare providers aiming to reduce the risk of breast cancer recurrence and improve treatment outcomes.